(12) United States Patent (10) Patent No.: US 9.248,266 B2 Chandler Et Al

(12) United States Patent (10) Patent No.: US 9.248,266 B2 Chandler Et Al

USOO9248266B2 (12) United States Patent (10) Patent No.: US 9.248,266 B2 Chandler et al. (45) Date of Patent: Feb. 2, 2016 (54) METHOD OF PERFORMINGA (58) Field of Classification Search SPHENOPALATINE GANGLION BLOCK CPC ... A61 B 17/3421: A61B 1/06; A61B 1/00082: PROCEDURE A61B 19/5202; A61M29/02: A61M29/00; A61M 2210/0681; A61M 2210/0618: A61M (71) Applicant: BIOVISION TECHNOLOGIES, LLC, 25/1002: A61M 25/10; A61M 25/04; A61M Golden, CO (US) 25/1018: A61M 2025/105: A61M 1/0009; A61M 1/062: A61M31/002: A61M31/00; (72) Inventors: Stephen W. Chandler, Montgomery, AL A61M3/0279; A61M3/0262: A61M3/0295 (US); David W. Sanso, Morrison, CO USPC ................. 600/249; 604/94.01, 95.02, 95.03, (US) 604/95.05, 96.01, 97.01, 514; 606/191, 606/192, 196, 198, 199 (73) Assignee: Biovision Technologies, LLC, Golden, See application file for complete search history. CO (US) (56) References Cited (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 U.S. PATENT DOCUMENTS U.S.C. 154(b) by 0 days. 2.493,326 A * 1/1950 Trinder ... ... 606,196 2,847.997 A * 8, 1958 Tibone .......................... 606, 196 Appl. No.: 14/712,722 (21) (Continued) (22) Filed: May 14, 2015 FOREIGN PATENT DOCUMENTS (65) Prior Publication Data CA 2266958 A1 10, 1999 US 2015/O258315A1 Sep. 17, 2015 EP 2522386 A2 11/2012 (Continued) Related U.S. Application Data OTHER PUBLICATIONS (63) Continuation of application No. 14/699.999, filed on Apr. 29, 2015, which is a continuation-in-part of Agro, et al., “Lightwand intubation using the Trachlight(TM): a brief application No. 14/572,353, filed on Dec. 16, 2014, review of current knowledge.” Canadian Journal of Anesthesia, which is a continuation-in-part of application No. (2000), pp. 592-599. 14/298,521, filed on Jun. 6, 2014. (Continued) (60) Provisional application No. 61/917,097, filed on Dec. Primary Examiner — Eduardo C Robert 17, 2013. Assistant Examiner — Michelle C Eckman (74) Attorney, Agent, or Firm — Faegre Baker Daniels LLP (51) Int. C. A6 IB I/06 (2006.01) (57) ABSTRACT A6M 3L/00 (2006.01) Methods and devices to quickly and accurately locate the sphenopalatine ganglion (SPG) while performing a spheno (Continued) palatine ganglion block procedure that introduces a medica (52) U.S. C. tion to the SPG. The methods and devices also prevent the CPC ............ A61M31/00 (2013.01); A61B I/00135 medication applied to the SPG from flowing down a patients (2013.01); A61B I/06 (2013.01); throat during the procedure. (Continued) 15 Claims, 33 Drawing Sheets Fictisi Siiks - Masal westbule, Nose as:-garns w Y-108 - 2004 ;Pride US 9.248,266 B2 Page 2 (51) Int. Cl. 6,733,440 B2 5/2004 Ailinger et al. A6 IB I/00 (2006.01) 2.93 E. 52; Marine et al. A6 IB 7/24 (2006.01) 8.76363 $56, Ranet al. A61M 2.5/10 (2013.01) 6,793,661 B2 9/2004 Hamilton et al. (52) U.S. Cl. 6,822.213 B2 11/2004 Stark CPC ......... A61B 1724 (2013.01); A61M 25/10182 6,853,858 B2 2/2005 Shalev (2013.11); A61M 25/1002 (2013.01); A61M 6,902,535 B2 6/2005 Eberhart et al. 7,025,923 B2 4/2006 Harhen et al. 25/1011 (2013.01); A61M 2025/1052 7,056,284 B2 6/2006 Martone et al. (2013.01); A61M 2202/048 (2013.01); A61M 7,056,287 B2 6/2006 Taylor et al. 2210/06 (2013.01) 7,081,097 B2 7/2006 Martone et al. 7,112,578 B2 9/2006 Levin 7,117,033 B2 10/2006 Shalev et al. (56) References Cited 7,120,489 B2 10/2006 Shalev et al. 7,131,969 B1 1 1/2006 Hovda et al. U.S. PATENT DOCUMENTS D534,216 S 12/2006 Makower et al. 2.936,760 A * 5, 1960 Gants ....................... 604/101.03 Zig R: 1399; SRita 3,049,125 A * 8,f 1962 Kriwkowitschh .............. 606, 196 7, 190,998J. W-1 B2 3/2007 Shalev et al. 3,664,330 A 5/1972 Deutsc 7.336,309 B2 2/2008 Stark 3,747,595 A * 7/1973 Grossan ........................ 601 160 7,361,168 B2 4/2008 Makower et al. 3,766,924. A * 10/1973 Pidgeon ........................ 606, 196 7,410,480 B2 8/2008 Muni et al. 3,800,788 A 4, 1974 White 7,419,497 B2 9/2008 Muni et al. 3,850,176 A * 1 1/1974 Gottschalk .................... 606, 196 3,903,893 A * 9/1975 Scheer .......................... 606, 196 7.462,175 B2 12/2008 Chang et al. 4,592,357. A 6, 1986 Ersek 7,500,971 B2 3/2009 Chang et al. 4,606,346 A * 8, 1986 Berget al... 606, 196 23: E: 2. ity al. 4,819,619 A * 4/1989 Augustine et al. ....... 128/200.26 7561919 B2 7/2009 Shalev et al. 4,883,465 A * 1 1/1989 Brennan ........ 604,96.01 7,636,597- W - B2 12/2009 Gross et al. 4,886,493 A * 12/1989 Yee ............................... 604,516 7,640,062 B2 12/2009 Shalev 4,887,593. A 12/1989 Wiley et al. 7,641,644 B2 1/2010 Chang et al. 5,024,658 A * 6/1991 Kozlov et al. ............ 604/101.04 7,642,563 B2 1/2010 Kang et al. 5,116,311 A * 5/1992 Lofstedt ........................ 604,516 7,645,272 B2 1/2010 Chang et al. 5,189,727 A 2f1993 Guerreri 7,648,367 B1 1/2010 Makower et al. 5, 193,525 A 3,f 1993 Silverstein et al.1 7,654,997 B2 2/2010 Makower et al. 5,213,115 A 5/1993 Zytkovicz et al. 7,678,099 B2 3/2010 Ressemann et al. 5,215,536 A 6/1993 Lampropoulos et al. 5.242.400 A 9, 1993 Blake et all 7.684,859 B2 3/2010 Shalev et al. 4- 4 e et al. 7.704,259 B2 4/2010 Kaplanet al. 5,370,640 A 12/1994 Kolff 7,717.933 B2 5/2010 Becker 5,446,070 A 8/1995 Mantelle 7,720,521 B2 5/2010 Chang et al. 5483,951 A 1/1996 Frassica et al. 7,727, 186 B2 6, 2010 Makower et al. 5,514,128. A 5/1996 Hillsman et al. 7.727,226 B2 6/2010 Chang et al. 5,531,676 A 7/1996f Edwards et al. 7,729,759 B2 6/2010 Shalev et al. 5,534,242 A 7/1996 Henry 7,740,642 B2 6/2010 Becker 5.546,964 A * 8/1996 Stangerup ..................... 128/898 7,749,515 B2 7/2010 Blumenfeld 5,599,304 A 2, 1997 Shaari 7,753,929 B2 7/2010 Becker 5,626,553 A 5, 1997 Frassica et al. 7,753,930 B2 7/2010 Becker 5,647,847 A 7, 1997 Lafontaine et al. 7,771.409 B2 8/2010 Chang et al. 5,667.476 A 9, 1997 Frassica et al. 7,785,315 B1 8/2010 Muni et al. 5,676,635 A 10/1997 Levin 7,799,337 B2 9/2010 Levin 5,685,822 A 1 1/1997 Harhen T.8O3.150 B2 9, 2010 Ch 1 5,718.6665,73587. A 2,4/1998 1998 ShanthaAlarcon 7,837.672wW - B2* 11/2010 Intocciaanget al....................... 604f 540 5,752.971 A 5/1998 Rosenbluth et al. 7,842,062 B2 11/2010 Keith et al. f hanth 7,854,744 B2 12/2010 Becker $499 A .22 Shata 7,877,147 B2 1/2011 Shalev et al. 5,827.177 A 10/1998 Oneda et al. 788: E: 33. Rita 5,827,224. A * 10/1998f Shippert ......................... 604f73 7,908,000w - B2 3/2011 Shalev 5,876,32933 AA. 3/1999E. HarhenE. 7,918,871D640,374 SB2 4/20116, 2011 TruittLiu et etal. al. 6,027.478 A * 2/2000 Katz ........................ 604.102.01 D643,115 S 8/2011 Gonzales et al. 6,106,496 A 8, 2000 Arnissolle 8,010, 189 B2 8, 2011 Shalev 6,174,280 B1 1/2001f Onedah et al. 8.012,084 B2 *ck 9/2011 Machida ....................... 600,115 6,190,330 B1, 2, 2001 Harhen 8,025,635 B2 9/2011 Eaton et al. 6,322,542 B 1 * 1 1/2001 Nilson et al. .................. 604/257 6,350,231 B1 2/2002 Ailinger et al. 8,052,693 B2 11/2011 Shahoian 6.350.465 B1* 2/2002 Jonnalagadda et al. ...... 424/434 8,080,000 B2 12/2011 Makower et al. 8,088,101 B2 1/2012 Chang et al. 6,394,093 B1* 5/2002 Lethi. ... 128.207.18 8,090,433 B2 1/2012 Makower et al. 6,413.499 B1* 7/2002 Clay ............................... 424/49 8.100.933 B2 1/2012 Beck 6,432,986 B2 8/2002 Levin J. WW ecker 6,461,294 B1 10/2002 Oneda et al. .. R: 3: E. et al. 6,491,940 B1* 12/2002 Levin ............................ 424/434 J. J. ecker 6,529,756 B1 3/2003 Phan et al. 8,118,757 B2 2/2012 Morriss 6,530,881 B1 3/2003 Ailinger et al. 8,123,722 B2 2/2012 Chang et al. 6,579,582 B1 6, 2003 Harhen et al. 8,142,422 B2 3/2012 Makower et al. 6,607,546 B1 8, 2003 Murken D658,291 S 4/2012 Jenkins et al.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    53 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us